170 related articles for article (PubMed ID: 21681417)
1. Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration.
Kim JM; Park KH; Kim CY; Kim HK; Kim TW; Kim MS
Jpn J Ophthalmol; 2011 Jul; 55(4):356-361. PubMed ID: 21681417
[TBL] [Abstract][Full Text] [Related]
2. Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.
Cho SW; Kim JM; Park KH; Choi CY
Jpn J Ophthalmol; 2010 Sep; 54(5):407-13. PubMed ID: 21052902
[TBL] [Abstract][Full Text] [Related]
3. Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
Inatani M; Orii Y; Iwasaki K; Arimura S; Sunagawa H; Shiokawa M; Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Manabe K; Tanito M
Adv Ther; 2023 Sep; 40(9):4074-4092. PubMed ID: 37452961
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
Konstas AG; Katsimpris IE; Kaltsos K; Georgiadou I; Kordelou A; Nelson LA; Stewart WC
Eye (Lond); 2008 Nov; 22(11):1391-7. PubMed ID: 17571086
[TBL] [Abstract][Full Text] [Related]
5. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma.
Joshi SR; Akat PB; Ramanand JB; Ramanand SJ; Karande VB; Jain SS
Indian J Ophthalmol; 2013 Dec; 61(12):765-7. PubMed ID: 24008808
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Intraocular Pressure-Lowering Effect and Safety of Preservative-Free And Preservative-Containing Brimonidine/Timolol Fixed-Combination Ophthalmic Solutions in Patients with Open-Angle Glaucoma.
Kim JM; Kim TW; Park SW; Park HL; Hwang YH; Jeoung JW; Kim CY
Semin Ophthalmol; 2021 Apr; 36(3):103-109. PubMed ID: 33734910
[No Abstract] [Full Text] [Related]
8. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
García-López A; Paczka JA; Jiménez-Román J; Hartleben C
BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
Kim JM; Kim TW; Kim CY; Kim HK; Park KH
Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
[TBL] [Abstract][Full Text] [Related]
10. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
[TBL] [Abstract][Full Text] [Related]
11. Diurnal intraocular pressure efficacy of the timolol-brimonidine fixed combination and the timolol-dorzolamide fixed combination as a first choice therapy in patients with pseudoexfoliation glaucoma.
Yüksel N; Gök M; Altıntaş O; Cağlar Y
Curr Eye Res; 2011 Sep; 36(9):804-8. PubMed ID: 21851166
[TBL] [Abstract][Full Text] [Related]
12. Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients.
Aihara M; Adachi M; Matsuo H; Togano T; Fukuchi T; Sasaki N;
Acta Ophthalmol; 2017 Dec; 95(8):e720-e726. PubMed ID: 28371482
[TBL] [Abstract][Full Text] [Related]
13. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
Frampton JE
Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma.
Konstas AG; Quaranta L; Yan DB; Mikropoulos DG; Riva I; Gill NK; Barton K; Haidich AB
Eye (Lond); 2012 Jan; 26(1):80-7. PubMed ID: 21960068
[TBL] [Abstract][Full Text] [Related]
15. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fixed combinations of dorzolamide/timolol and brimonidine/timolol in patients with primary open-angle glaucoma.
Gulkilik G; Oba E; Odabası M
Int Ophthalmol; 2011 Dec; 31(6):447-51. PubMed ID: 22207522
[TBL] [Abstract][Full Text] [Related]
17. Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
Katsanos A; Dastiridou AI; Fanariotis M; Kotoula M; Tsironi EE
J Ocul Pharmacol Ther; 2011 Feb; 27(1):67-71. PubMed ID: 21214361
[TBL] [Abstract][Full Text] [Related]
18. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
[TBL] [Abstract][Full Text] [Related]
19. Anterior segment morphology after acute primary angle closure treatment: a randomised study comparing iridoplasty and medical therapy.
Sng CC; Aquino MC; Liao J; Zheng C; Ang M; Chew PT
Br J Ophthalmol; 2016 Apr; 100(4):542-8. PubMed ID: 26294102
[TBL] [Abstract][Full Text] [Related]
20. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
Kóthy P; Holló G
Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
